Research
Measure the intact system. Resolve the hidden states.
We develop native and gas-phase structural mass spectrometry methods for RNAs, biotherapeutics, and multicomponent biomolecular assemblies.
Nucleic Acid Self-Assembly
Nucleic acids can adopt complex structures and organize into higher-order assemblies through interactions governed by sequence, molecular environment, and chemical conditions. Understanding these processes is a fundamental challenge in nucleic acid biophysics.
Our laboratory develops and applies native mass spectrometry and charge detection mass spectrometry approaches to investigate molecular heterogeneity, assembly behavior, and structural organization in complex nucleic acid systems.
By connecting intact molecular measurements with controlled experimental perturbations, we aim to establish generalizable chemical principles governing nucleic acid assembly and stability. These insights have implications for understanding natural nucleic acid systems and informing nucleic acid nanotechnologies and therapeutics.

How Orbitrap CDMS measures individual ions

RNA Therapeutics
Orbitrap CDMS resolves full-length transcripts alongside truncations, overextensions, and noncovalent oligomers—directly at the intact RNA level.
Our Orbitrap CDMS workflows for kilobase-scale mRNAs distinguish full-length transcripts from process-related impurities and higher-order oligomers.
Research focus: Resolving RNA populations beyond the intended full-length transcript. Intact measurements connect sample heterogeneity to truncation, extension, and oligomer formation.
Shared methods: This program and our long-RNA research both use Orbitrap charge detection mass spectrometry. Individual-ion measurements extend intact-mass analysis to heterogeneous populations; native MS provides complementary information about assembly and composition. Explore native MS and CDMS →
Protein Therapeutics
Native IM–MS and activation workflows track gas-phase structural responses, stability shifts, and stress-dependent aggregation in therapeutic proteins.
We combine native mass, ion mobility, collision-induced unfolding, and surface-based activation to interrogate stability before and after controlled stress.
What we want to learn: How does a therapeutic protein respond to environmental stress? We compare mass distributions and activation-dependent ion-mobility fingerprints to track changes in assembly and stability.
Gas-phase unfolding: from compact ions to structural fingerprints
We gradually increase the energy delivered to protein ions and use ion mobility to follow the resulting structural transitions. Collision-induced unfolding (CIU) uses collisions with neutral gas; surface-induced unfolding (SIU) uses a surface impact. The resulting fingerprints help distinguish closely related protein forms and compare their responses to stress or ligand binding.
These measurements report relative gas-phase stability and activation-dependent structural transitions. Connecting them with solution measurements is a central part of our biotherapeutics work.


Targeted Protein Degradation
We use native MS to measure ternary-complex formation, stoichiometry, and solution-dependent assembly in targeted protein degradation systems.
Native MS provides a direct view of free, binary, and ternary species—connecting solution conditions to complex stoichiometry and cooperativity.
What we want to learn: Which complexes form when a target protein, a degrader, and an E3 ligase come together? Resolving free proteins and binary and ternary complexes helps guide comparisons across solution conditions.

How we work
Method development and biological application move together.
Preserve
Maintain native-like noncovalent interactions wherever the question demands it.
Resolve
Separate coexisting masses, charges, assembly states, and mobility-resolved populations.
Connect
Relate gas-phase observables to molecular stability, assembly, and function.
Methods connect the programs. Orbitrap CDMS supports both long-RNA and intact-mRNA analysis. Ion mobility and gas-phase unfolding connect protein and nucleic-acid structure studies, while native MS and structural activation methods support measurements across these biological systems.

